MedicarePartD.guide

A non-government resource built from CMS public data

Biologics for severe asthma and COPD on HealthSpring Extra Rx (S5617-353)

Dupixent, Nucala, Fasenra and Xolair, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), New York
Premium
$91.60/month
Deductible
$615.00, doesn't apply to tier 1 and 2
Change plan

3 of 4 Asthma and COPD biologics are covered on this plan. All 3 require prior authorization.

1 isn't on the formulary (Nucala).

  • Dupixent
    dupilumab
    Covered · prior auth
    from $2,061.09
    Tier 5
  • Fasenra
    benralizumab
    Covered · prior auth
    from $516.31
    Tier 5
  • Xolair
    omalizumab
    Covered · prior auth
    from $344.91
    Tier 5
Not on the formulary
Nucala

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list